BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1281 related articles for article (PubMed ID: 12427685)

  • 1. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.
    Brown JP; Josse RG;
    CMAJ; 2002 Nov; 167(10 Suppl):S1-34. PubMed ID: 12427685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
    CMAJ; 1996 Oct; 155(8):1113-33. PubMed ID: 8873639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.
    Meltzer S; Leiter L; Daneman D; Gerstein HC; Lau D; Ludwig S; Yale JF; Zinman B; Lillie D
    CMAJ; 1998; 159 Suppl 8(6):S1-29. PubMed ID: 9834731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.
    Hodsman A; Adachi J; Olszynski W
    CMAJ; 1996 Oct; 155(7):945-8. PubMed ID: 8837544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoporosis prevention, diagnosis, and therapy.
    NIH Consens Statement; 2000 Mar 27-29; 17(1):1-45. PubMed ID: 11525451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis Clinical Guideline. South African Medical Association--Osteoporosis Working Group.
    Hough S
    S Afr Med J; 2000 Sep; 90(9 Pt 2):907-44. PubMed ID: 11081144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
    Siminoski K; Josse RG
    CMAJ; 1996 Oct; 155(7):962-5. PubMed ID: 8837547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2006; 13(3):340-67; quiz 368-9. PubMed ID: 16735931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 4. Calcium nutrition and osteoporosis.
    Murray TM
    CMAJ; 1996 Oct; 155(7):935-9. PubMed ID: 8837543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
    Jones G; Hogan DB; Yendt E; Hanley DA
    CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 5. Physical activity as therapy for osteoporosis.
    Prior JC; Barr SI; Chow R; Faulkner RA
    CMAJ; 1996 Oct; 155(7):940-4. PubMed ID: 8925493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG
    CMAJ; 1996 Oct; 155(7):929-34. PubMed ID: 8837542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of postmenopausal osteoporosis: position statement of the North American Menopause Society.
    North American Menopause Society.
    Menopause; 2002; 9(2):84-101. PubMed ID: 11875327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postmenopausal osteoporosis].
    László A
    Orv Hetil; 2004 Jan; 145(1):3-13. PubMed ID: 15222134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
    Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis management in post-menopausal women.
    Christenson ES; Jiang X; Kagan R; Schnatz P
    Minerva Ginecol; 2012 Jun; 64(3):181-94. PubMed ID: 22635014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis.
    Blair MM; Carson DS; Barrington R
    J Fam Pract; 2000 Sep; 49(9):839-48. PubMed ID: 11032210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical strategies to address patients' concerns in osteoporosis management with bisphosphonates.
    Cole RE
    Postgrad Med; 2011 Mar; 123(2):131-44. PubMed ID: 21474901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.